Suxibuzone is a pyrazolidine derivative and a prodrug of phenylbutazone, commonly used as a non-steroidal anti-inflammatory drug in veterinary medicine, particularly for horses. It functions as an anti-inflammatory and analgesic agent in a research and manufacturing context.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Suxibuzone?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Noramidopyrine
pharmaceutical raw material
Acemetacin
pharmaceutical raw material
Antipyrine
pharmaceutical raw material
Valdecoxib
pharmaceutical raw material
Aceclofenac-d4 (phenyl-d4-acetoxy)
pharmaceutical raw material
Vildagliptin
pharmaceutical raw material
Haloperidol Decanoate N-Oxide
pharmaceutical raw material
Rac-Sitagliptin-d4 HCl
pharmaceutical raw material
The international HS code for Suxibuzone (CAS 27470-51-5) is 2933.19.
2933.19
2933 19 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid
ONWXNHPOAGOMTG-UHFFFAOYSA-N
CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)COC(=O)CCC(=O)O
Sourcing Suxibuzone?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.